Idiopathic pulmonary fibrosis

被引:5
作者
Hennion, Nathan [1 ]
Desseyn, Jean-Luc [1 ]
Gottrand, Frederic [1 ]
Wemeau-Stervinou, Lidwine [2 ]
Gouyer, Valerie [1 ]
机构
[1] Univ Lille, INSERM, CHU Lille, U1286 Infinite, F-59000 Lille, France
[2] CHU Lille, Ctr reference constitutif Ies Malad pulmonaires r, Serv pneumol & immuno allergol, F-59000 Lille, France
来源
M S-MEDECINE SCIENCES | 2022年 / 38卷 / 6-7期
关键词
INTERSTITIAL LUNG-DISEASE; DOUBLE-BLIND; PIRFENIDONE;
D O I
10.1051/medsci/2022084
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal lung disease of unknown origin. It is characterized by aberrant scarring of the alveolar epithelium leading to an accumulation of extracellular matrix (ECM). Fibroblastic foci, consisting of fibroblasts and myofibroblasts, are responsible for the excessive production of ECM. The two therapeutic molecules available on the market to date only allow to slow down the evolution of the disease. In this review, we present the mechanisms involved in the progression of the disease, its treatments and the study models.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 34 条
[1]   PLATELET-DERIVED GROWTH-FACTOR IN IDIOPATHIC PULMONARY FIBROSIS [J].
ANTONIADES, HN ;
BRAVO, MA ;
AVILA, RE ;
GALANOPOULOS, T ;
NEVILLEGOLDEN, J ;
MAXWELL, M ;
SELMAN, M .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (04) :1055-1064
[2]   Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial [J].
Behr, Juergen ;
Prasse, Antje ;
Kreuter, Michael ;
Johow, Johannes ;
Rabe, Klaus F. ;
Bonella, Francesco ;
Bonnet, Reiner ;
Grohe, Christian ;
Held, Matthias ;
Wilkens, Heinrike ;
Hammerl, Peter ;
Koschel, Dirk ;
Blaas, Stefan ;
Wirtz, Hubert ;
Ficker, Joachim H. ;
Neumeister, Wolfgang ;
Schoenfeld, Nicolas ;
Claussen, Martin ;
Kneidinger, Nikolaus ;
Frankenberger, Marion ;
Hummler, Simone ;
Kahn, Nicolas ;
Tello, Silke ;
Freise, Julia ;
Welte, Tobias ;
Neuser, Petra ;
Guenther, Andreas .
LANCET RESPIRATORY MEDICINE, 2021, 9 (05) :476-486
[3]   Future Directions in Idiopathic Pulmonary Fibrosis Research [J].
Blackwell, Timothy S. ;
Tager, Andrew M. ;
Borok, Zea ;
Moore, Bethany B. ;
Schwartz, David A. ;
Anstrom, Kevin J. ;
Bar-Joseph, Ziv ;
Bitterman, Peter ;
Blackburn, Michael R. ;
Bradford, William ;
Brown, Kevin K. ;
Chapman, Harold A. ;
Collard, Harold R. ;
Cosgrove, Gregory P. ;
Deterding, Robin ;
Doyle, Ramona ;
Flaherty, Kevin R. ;
Garcia, Christine Kim ;
Hagood, James S. ;
Henke, Craig A. ;
Herzog, Erica ;
Hogaboam, Cory M. ;
Horowitz, Jeffrey C. ;
King, Talmadge E., Jr. ;
Loyd, James E. ;
Lawson, William E. ;
Marsh, Clay B. ;
Noble, Paul W. ;
Noth, Imre ;
Sheppard, Dean ;
Olsson, Julie ;
Ortiz, Luis A. ;
O'Riordan, Thomas G. ;
Oury, Tim D. ;
Raghu, Ganesh ;
Roman, Jesse ;
Sime, Patricia J. ;
Sisson, Thomas H. ;
Tschumperlin, Daniel ;
Violette, Shelia M. ;
Weaver, Timothy E. ;
Wells, Rebecca G. ;
White, Eric S. ;
Kaminski, Naftali ;
Martinez, Fernando J. ;
Wynn, Thomas A. ;
Thannickal, Victor J. ;
Eu, Jerry P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (02) :214-222
[4]  
Cottin V., 2022, REV MAL RESPIR
[5]   Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines [J].
Cottin, Vincent ;
Crestani, Bruno ;
Valeyre, Dominique ;
Wallaert, Benoit ;
Cadranel, Jacques ;
Dalphin, Jean-Charles ;
Delaval, Philippe ;
Israel-Biet, Dominique ;
Kessler, Romain ;
Reynaud-Gaubert, Martine ;
Aguilaniu, Bernard ;
Bouquillon, Benoit ;
Carre, Philippe ;
Danel, Claire ;
Faivre, Jean-Baptiste ;
Ferretti, Gilbert ;
Just, Nicolas ;
Kouzan, Serge ;
Lebargy, Francois ;
Marchand-Adam, Sylvain ;
Philippe, Bruno ;
Prevot, Gregoire ;
Stach, Bruno ;
Thivolet-Bejui, Francoise ;
Cordier, Jean-Francois .
EUROPEAN RESPIRATORY REVIEW, 2014, 23 (132) :193-214
[6]   Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities [J].
Cruwys, Simon ;
Hein, Peter ;
Humphries, Bob ;
Black, Darcey .
DRUG DISCOVERY TODAY, 2020, 25 (12) :2277-2283
[7]   The structure of mucins conditions the viscoelastic properties of the mucus gel [J].
Desseyn, J. L. ;
Demouveaux, Bastien ;
Gouyer, Valerie ;
Magnien, Mylene ;
Plet, Segolene ;
Gottrand, Frederic ;
Narita, Tetsuharu ;
Desseyn, Jean-Luc .
M S-MEDECINE SCIENCES, 2018, 34 (10) :806-812
[8]   Differentiation of mucous cells and regulation of the gelling mucin Muc5b: a new tool for ex vivo studies and preclinical studies in vivo [J].
Desseyn, Jean-Luc ;
Portal, Celine ;
Gottrand, Frederic ;
Gouyer, Valerie .
M S-MEDECINE SCIENCES, 2017, 33 (05) :478-480
[9]   Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris [J].
Duchemann, Boris ;
Annesi-Maesano, Isabella ;
de Naurois, Camille Jacobe ;
Sanyal, Shreosi ;
Brillet, Pierre-Yves ;
Brauner, Michel ;
Kambouchner, Marianne ;
Huynh, Sophie ;
Naccache, Jean Marc ;
Borie, Raphael ;
Piquet, Jacques ;
Mekinian, Arsene ;
Virally, Jerome ;
Uzunhan, Yurdagul ;
Cadranel, Jacques ;
Crestani, Bruno ;
Fain, Olivier ;
Lhote, Francois ;
Dhote, Robin ;
Saidenberg-Kermanac'h, Nathalie ;
Rosental, Paul-Andre ;
Valeyre, Dominique ;
Nunes, Hilario .
EUROPEAN RESPIRATORY JOURNAL, 2017, 50 (02)
[10]   IDIOPATHIC PULMONARY FIBROSIS: A GENETIC DISEASE THAT INVOLVES MUCOCILIARY DYSFUNCTION OF THE PERIPHERAL AIRWAYS [J].
Evans, Christopher M. ;
Fingerlin, Tasha E. ;
Schwarz, Marvin I. ;
Lynch, David ;
Kurche, Jonathan ;
Warg, Laura ;
Yang, Ivana V. ;
Schwartz, David A. .
PHYSIOLOGICAL REVIEWS, 2016, 96 (04) :1567-1591